In a similar fashion, ticagrelor, beyond its antiplatelet effect, reduced macrophage NLRP3 in vitro in acute coronary syndrome patients (Huang et al. 2021), and following myocardial ischemia reperfusion-induced acute lung injury in rats (Dai et al. 2024). The gene discussed is NLRP3; the disease is acute coronary syndrome.